FDA and Manufacturers Intensify Concerns about Data Integrity

被引：0
作者：
Wechsler, Jill
机构：
来源：
BIOPHARM INTERNATIONAL | 2016年 / 29卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
[31]   FDA and Manufacturers Ponder Biosimilars Pathway [J].
Wechsler, Jill .
BIOPHARM INTERNATIONAL, 2011, 24 (07) :12-14
[32]   Transformative medicines challenge FDA and manufacturers [J].
Wechsler, Jill .
Pharmaceutical Technology, 2017, 41 (12) :12-13
[33]   FDA Issues Updates for Device Manufacturers [J].
Journal of Validation Technology, 2021, 27 (05) :1-2
[34]   Balancing data integrity concerns with ethical considerations in online research [J].
Simone, Melissa .
INTERNATIONAL JOURNAL OF EATING DISORDERS, 2022, 55 (02) :290-291
[35]   Concerns mount over data integrity and compliance issues abroad [J].
Shanley, Agnes .
Pharmaceutical Technology, 2016, 40 (03) :26-29
[36]   INADEQUATE INFORMATION ABOUT DRUG OVERDOSAGE IN MANUFACTURERS DATA SHEETS [J].
NILLINGWORTH, R ;
PRESCOTT, LF .
BMJ-BRITISH MEDICAL JOURNAL, 1980, 280 (6229) :1418-1418
[37]   ORCID: Issues and concerns about its use for academic purposes and research integrity [J].
Teixeira da Silva, Jaime A. .
ANNALS OF LIBRARY AND INFORMATION STUDIES, 2020, 67 (04) :246-250
[38]   Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval [J].
Turner, Erick H. .
LANCET PSYCHIATRY, 2019, 6 (12) :977-979
[39]   FDA advisers want more data about phenylephrine [J].
Traynor, Kate .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (03) :193-194
[40]   RESIDUES AND OTHER FDA CONCERNS [J].
CRAWFORD, LM .
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1984, 185 (03) :332-332
12345